Selective Retinal Pigment Epithelium Laser Therapy for Macular Disease of the Retina

Clinical trial NCT02088151 · TERMINATED

Trial details

NCT number: NCT02088151
Sponsor: Insel Gruppe AG, University Hospital Bern
Status: TERMINATED
Phase: Not Applicable
Study type: INTERVENTIONAL

Macular Edema Central Serous Chorioretinopathy Retinal Vein Occlusion Age-related Macular Degeneration Retinal Neovascularization

Start date: 2010-06-01
Primary completion: 2022-02-01
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.